Aclaris Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13M | 3.4M | 3.75 |
| 2025-03-31 | $108k | 71k | 1.53 |
| 2024-06-30 | $15k | 14k | 1.10 |
| 2023-09-30 | $72k | 11k | 6.85 |
| 2022-12-31 | $323k | 21k | 15.75 |
| 2022-09-30 | $1.7M | 106k | 15.57 |
| 2022-03-31 | $3.6M | 210k | 17.24 |
| 2021-12-31 | $6.8M | 466k | 14.54 |
| 2021-09-30 | $2.9M | 162k | 18.00 |
| 2021-06-30 | $2.7M | 154k | 17.56 |
| 2018-12-31 | $2.3M | 315k | 7.39 |
| 2018-09-30 | $8.6M | 590k | 14.52 |
| 2018-06-30 | $14M | 700k | 19.97 |
| 2018-03-31 | $17M | 986k | 17.52 |
| 2017-12-31 | $23M | 928k | 24.66 |
| 2017-09-30 | $12M | 467k | 25.81 |
| 2017-06-30 | $11M | 420k | 27.12 |
| 2017-03-31 | $12M | 399k | 29.82 |
| 2016-12-31 | $9.5M | 350k | 27.14 |
| 2016-09-30 | $2.5M | 99k | 25.61 |